Thomas Dubin has served on the Notable Board of Directors since 2023. During the last five years, Dubin has served as an advisor and board member to several biopharma and other companies.
From 2001 through 2013, Dubin was the chief legal officer and member of the core executive team that grew Alexion Pharmaceuticals from development stage to membership in the S&P 500. At Alexion, he led legal, government affairs, pricing and reimbursement, human resources, corporate communications and other functions, and held commercial responsibility for the company’s Australasia region. Prior to Alexion, Dubin served as vice president and general counsel of ChiRex, Inc. and assistant general counsel of Warner-Lambert Company. Dubin began his career as a corporate attorney with Cravath, Swaine & Moore in New York City. He currently serves as executive chair of Cellphire Therapeutics, chair of Norwalk Hospital, board member of Connecticut Innovations, member of the Yale School of Public Health Leadership Council and advisory board member of Mythic Pharmaceuticals. Dubin was a board member of Bioblast Pharmaceuticals (Nasdaq: ORPN) from 2015 to 2018, and a trustee of American Jewish World Service from 2014 to 2021.
Dubin earned his juris doctor degree from New York University School of Law, New York, N.Y.; his master’s degree in public health from Yale University School of Public Health in New Haven, Conn.; and his bachelor of arts degree from Amherst College, Amherst, Mass., cum laude.
